|
RNF5P1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.821000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.547400E-01 |
| Normal-vs-Stage2 |
4.567800E-01 |
| Normal-vs-Stage3 |
4.025700E-02 |
| Normal-vs-Stage4 |
6.444000E-02 |
| Stage1-vs-Stage2 |
1.814430E-01 |
| Stage1-vs-Stage3 |
2.795100E-03 |
| Stage1-vs-Stage4 |
8.220300E-03 |
| Stage2-vs-Stage3 |
3.716600E-01 |
| Stage2-vs-Stage4 |
3.810400E-01 |
| Stage3-vs-Stage4 |
9.415000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.269200E-01 |
| Normal-vs-AfricanAmerican |
4.848400E-01 |
| Normal-vs-Asian |
9.400200E-01 |
| Caucasian-vs-AfricanAmerican |
1.553980E-01 |
| Caucasian-vs-Asian |
7.397800E-01 |
| AfricanAmerican-vs-Asian |
8.353200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.142760E-01 |
| Normal-vs-Female |
3.543000E-01 |
| Male-vs-Female |
6.422800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.106600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.970400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.309800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.316600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.806000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.381800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.494000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.044400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.154000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.885200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.614560E-01 |
| Normal-vs-Grade 2 |
6.787000E-01 |
| Normal-vs-Grade 3 |
7.716000E-01 |
| Normal-vs-Grade 4 |
8.27770000000339E-05 |
| Grade 1-vs-Grade 2 |
3.918400E-01 |
| Grade 1-vs-Grade 3 |
2.536800E-01 |
| Grade 1-vs-Grade 4 |
1.982700E-03 |
| Grade 2-vs-Grade 3 |
4.531600E-01 |
| Grade 2-vs-Grade 4 |
3.72640000000368E-05 |
| Grade 3-vs-Grade 4 |
2.791800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.496300E-03 |
| Normal-vs-ccB subtype |
1.75239999955501E-07 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.559600E-01 |
| Normal-vs-N1 |
1.641020E-01 |
| N0-vs-N1 |
1.641190E-01 |
|
|
